Bone Probe Market Report: Trends, Forecast and Competitive Analysis to 2035

Bone Probe Market

The future of the global bone probe market looks promising with opportunities in the hospital and ambulatory surgery center markets. The global bone probe market is expected to reach an estimated $1,920 million by 2035 from $964 million in 2027 with a CAGR of 9.0% from 2027 to 2035. The major drivers for this market are the increasing demand for advanced medical technologies, the rising preference for minimally invasive procedures, and the growing number of orthopedic surgeries.

• Lucintel forecasts that, within the type category, angled curved is expected to witness the highest growth over the forecast period due to because of better maneuverability in complex surgical situations.
• Within the application category, hospital is expected to witness higher growth over the forecast period due to because of more orthopedic and spinal surgical procedures being done.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period due to because of greater surgical procedures being done in the area.

Emerging Trends in Bone Probe Market

The trend in bone probe technology is shifting toward tools designed for minimally invasive surgery, infection control, and more precise methods to assess and evaluate surgical tissue. Between 2025 and 2027, hospitals will purchase more ergonomic and traceable technology, while systems will become more tailored to meet the unique demands of outpatient orthopedics and trauma care. Lucintel predicts market growth and development will become more consistent with the growth of surgical procedures and the need to replace outdated technologies.

• Minimally Invasive Surgery: Increased demand for thin, atraumatic bone probes stems from increasingly smaller incision sites and the rise in image-guided orthopedic surgery. Many hospitals incorporating navigation systems in 2025 will integrate them with precision instruments to improve the placement of orthopedic navigation devices. With decreasing healing time and the increasing demand for more compact designs, manufacturers will be incentivized to reduce the size of all components of their technology.
• Smart Instrumentation: With the advent of digital surgery suites, manufacturers have been incentivized to produce surgical instruments that include identification, usage record, and integration with surgical planning software. Radio Frequency Identification systems that are used in combination with an automated sterile supply system in some European hospitals in 2025, can log the usage history for each instrument. Market revenue will be justified by increasing customization of technology aimed at meeting unique customer requirements for traceability over the next three to five years."
• Infection-control Design: Cost pressures surrounding sterilization and surgical-site infections, as well as the costs of associated litigation, are in excess of twenty billion dollars annually at U.S. hospitals. The impact is pushing suppliers to ease the burden through options that include detachable components and single-use parts or alternatives. This will force a redefinition of product specifications due to the proactive analysis of contamination risk by procurement teams.
• Material Engineering: Companies are investing in more robust processes for the manufacture of lightweight devices with greater radiolucency and fatigue resistance. Medical device manufacturers are also investing in the use of new rapid manufacturing technologies that provide prototypes based on patient specific design. Material selection will allow manufacturers to meet the demands of the surgeon for products that are strong, yet lightweight, do not interfere with the quality of the imaging, and do not allow the surgeon's hands to become fatigued.
• Regional Supply Diversification: Device manufacturers are qualifying additional suppliers and regional finishing capacity due to pandemic-related supply chain disruptions. It is expected that 2025 procurement practices will require dual sourcing for critical surgical instruments. This will affect inventory levels and prices throughout North America, Europe and Asia-Pacific.

Due to replacement and supply rational purchasing efforts and gradual increases in orthopedic procedures, demand should remain constant. Reliable metallurgy and compliant workflows will also matter. Standard reusable probes are expected to remain constant, however, growth should occur in specialized products that support MIS (Minimally Invasive Surgery), Imaging, and Infection Control requirements.

Recent Developments in the Bone Probe Market

The market for bone probes is growing but slowly, and in a business-meaningful way, from 2025 to 2027. Demand is tied to the increase in spinal, trauma and reconstructive joint surgeries, and hospitals prefer to use instruments that can be used multiple times and traced. In Lucintel's view, competing companies will focus more on design and bundling instruments together to be used with imaging, as opposed to selling single standalone surgical instruments.

• FDA Quality-system Transition: The FDA's QMS Regulations Act will go into effect in February of 2026. As a result of this Act, device manufacturing will come more into compliance with ISO 13485. This will not only increase the documentation requirements, but also the requirements on supplier control, especially for smaller manufacturers of bone probes, causing them to merge or go out of business.
• Stryker's Growing Portfolio: Stryker has reported an 11% growth in 2025 IQ1 organic sales, and this strengthens Stryker's ability to further expand its orthopedic surgical instruments and acquisitions. The larger platforms will be able to add bone probes to their inventory along with navigation, trauma, and arthroplasty sets, which will negatively impact small independent probe companies in the next 3 to 5 years.
• Integration of Surgical Robots: Stryker has announced the widening of the distribution of the Mako robotic system in additional international locations. Although bone probes are manual instruments, the need for design and tracking of surgical instruments for use with Mako robotic systems will increase demand for instruments that are designed for use with robots and navigation.
• Hospital Reprocessing Scrutiny: AAMI's 2025 survey found that 67% of healthcare organizations cited issues caused by limited staff or capacity in their sterile processing departments. As hospitals begin to rely on systems with more efficient processing, the lifecycle cost, not the purchase price, will become a focus for buyers.
• Additive Manufacturing: That same month (March 2025), the FDA published new guidance on additive manufacturing that included design validation, process control, and post-processing. The new guidance focuses more on design flexibility to meet changing customer needs and helps validate surgical tools that incorporate customized solutions. Over the next 5 years, the market is predicted to gravitate toward companies that have specialized offerings and improved additive manufacturing.

Continued growth in the number of procedures performed will not define the market. Many healthcare organizations are analyzing the impacts of sterilization, repair, and the utilization of medical devices. There is a clear focus on the purchasing of devices that enhance the overall procedural offering. Within public hospitals, price competition will continue to be dominant.

Strategic Growth Opportunities in the Bone Probe Market

The bone probe market is projected to undergo a shift to a more commercial phase between 2024 and 2026 given the expected surges in orthopedic procedures, image-guided surgeries, and osteo diagnostics to be performed on an outpatient basis. Because of the reluctance of hospitals to make larger capital investments and the resistance of instrument developers to make ergonomic and evidence-based improvements, market players of the future are predicted to focus on procedures and specialization. Lucintel also predicts a shift in procurement from basic instruments to integrated procedural systems.

• Image-guided Probes: Navigation-compatible probes help provide precise bone targeting during trauma and spine surgical procedures. In January 2025, the FDA listed more than 1,000 active surgical navigation device records. In the next 3 to 5 years, purchasing will favor integrated instruments over navigation systems.
• Outpatient Orthopedics: Journey orthopedic surgeries would be aided by compact, easy to sterilize and set up surgical bone probes. The US had over 11.5 million ambulatory surgery center procedures in 2023, as per the report by MedPAC in March 2025. The high number of outpatient procedures will create a demand for easy to use and durable bone probes.
• Dental Implant Applications: The increased need to confirm cortical borders and implant sites by dental surgeons has made the use of bone probes tactile and necessary. According to the FDI in September 2025, over 3.5 billion people worldwide suffer from oral diseases. Bone probe suppliers have the opportunity to expand their markets through dental distributors and implantation surgical kit providers in the next 5 years.
• Single-use Sterile Products: Disposable elements hasten workflow and minimize expense from cleaning and risk of cross contamination in high volume environments. In February 2025, the CDC stated that surgical instruments must be sterilized between each patient use. This situational need supports systems using high-quality sterile products and speed over cost.
• Specialty Probes for Oncology: The structure of oncology procedures, and especially bone tumor biopsies and resections, suggest that deploying probes designed for irregular, and even less-than-optimal anatomy, and for precise sampling, will have a clear value proposition. The American Cancer Society estimates that in the United States for 2025, there will be 2.0 million new cases of cancer, published in January 2025. Oncology design focus will provide a clear value proposition at higher margins through the clinical evidence and specialized sales channels.

The most promising opportunities exist where the use of the probe becomes part of the overall procedure. When instruments are used as a standalone tool, the key buyer is the hospital. Focused partnership distribution of the instruments, especially within dental and ambulatory settings, will substantiate a higher margin. Designing a product with value-add ergonomic features will provide a high level of differentiation in procurement. Although the majority of devices used in procedures will be everyday low-cost products, efforts to drive the market should be focused on specialized systems that are evidence-based.

Bone Probe Market Drivers and Challenges

Technological, Economic, and Regulatory Forces Drive bone probe market Growth and Limitations. Number of orthopedic surgeries, improvement in imaging, and adoption of minimally invasive techniques and the demand for more precise surgical instruments drive this growth. High development costs, complexity of regulatory systems, restricted reimbursement and supply chain concerns limit market growth. According to Lucintel, successful companies will need to strike a balance between innovation, reliability, cost and regulatory compliance to capture new opportunities in hospitals, outpatient surgery centers, and specialty orthopedic clinics.

The factors responsible for driving this market include:

• Surgical Procedures: There is an increasing demand for the most accurate bone probes due to the increasing number of orthopedic trauma, spinal, dentoalveolar and joint replacement procedures. The aging population, sports injuries, osteoporosis, and road accidents create sustained demand for instruments to identify the structure of bones, detect bone defects and assess the position of implants. Per the United Nations, in January 2025, it was anticipated that 10% of the world's population was 65 years or older. as a result, this reinforces the importance of orthopedic care. Over the next three to five years, it will be likely that hospitals will prioritize the purchase of new bone probes due to the increasing number of procedures.
• Technology Improvements: The introduction of minimally invasive technologies, like digital navigation, robotic technology, smart sensors, high resolution imaging, and smart tools will help develop more precise and better tools for surgeons to use. During surgery, especially; smart tools that have the ability to be used to measure depth, sense resistance and command surgical systems can help surgery be done with less uncertainty and be easier to log. In February 2025, surgery systems that used robotic technology became more popular, especially in orthopedic procedures. In the next three to five years, the use of smart probes, which will help surgeons with their accuracy and reduce the length of the procedures and help achieve better results for patients, will be more widely used.
• Product Innovation: More options in probe design are happening and manufacturers are focusing on offering customizable options for users. Options include design of smarter devices, materials that resist the growth of bacteria, radio-transparent designs, and techniques to modularize components that fit the needs of trauma, dental, prosthetic and spinal applications. In the orthopedic market, many hospitals offered the option of single use devices in surgical procedures and continued to expand this option in 2025. Over the next three to five years, the ability to offer probes that integrate smart systems, help reduce infections, protect sterility, and offer more flexibility and precision for surgeons, will help separate products in the market.
• Regulatory Support: Increased clarity for medical device pathways, quality-system requirements, and government funding for healthcare infrastructure strengthens confidence in compliant bone-probe products. Regulatory oversight also allows manufacturers to enter new markets and prompts hospitals to use standardized instruments. In February 2025, the United States continued to follow the FDA's established 510(k) framework, which, in most cases, requires manufacturers to demonstrate substantial equivalence for devices covered by the framework. In the next 3-5 years, predictable regulatory systems will enable product launches, but manufacturers will need to provide more comprehensive clinical data, Traceability and post-market surveillance.
• Manufacturing Efficiency: Through automation, production waste will decrease, allowing manufacturers to produce custom bone probes with reduced batch volumes. Improved supply planning and regional manufacturing will also reduce delivery times while increasing flexibility. In April 2025, many medical device manufacturers accelerated the digital integration of quality control systems to manage a greater burden of compliance documentation. In the next 3-5 years, efficient production will allow suppliers to offer lower prices, consistent quality, and better availability to hospitals while meeting cost-effectiveness demands.

The challenges facing this market include:

• Building The Instruments: Advanced bone-related probes can include sensors, special coatings, navigation compatibility, and/or disposables. All of these can increase the price beyond what can be justified when considering price competition with conventional instruments. Facilities with financial constraints, as well as low case volume and/or low reimbursement, opt for basic reusable tools. During January 2025 across many markets, suppliers in the healthcare industry still faced considerable pressure to decrease supplies for use in the operating room, while still maintaining the expected level of care. Until at least the next 3-5 years, most suppliers will see a slow adoption of more premium devices due to an absence of significant price reductions and the absence of improvements on the procedures that result in a reduction in case time, case costs, or an improvement in case reduction.
• Complex Regulations: Bone probes may require different safety, biocompatibility, case validation, sterilization, and labeling requirements in different regions, and may require different systems related to quality assurance and case validation. Changes in documentation or classification can significantly impact time to market and increase compliance costs for small companies. Even in May 2025, the EU's Medical Device Regulations required an extensive amount of documentation, case validation, and post market surveillance, for devices within the regulations. It is anticipated in the next 3-5 years that more regulations will be implemented for an even greater amount of time, thus creating a need for companies to have even stronger international quality systems, more elaborate compliance divisions, and standardized case evidence.
• Supply Chain Risks: The market may experience shortages and disruptions due to reliance supply chains that include specialty metals, precision components, coatings, sterilization capacity, and contract manufacturers. There may be delays in the instrument replacement for hospitals, and increased logistics and inventory costs for manufacturers. During June 2025, suppliers of medical devices around the world continued to manage high volatility and extended lead times for procurement for several regions. For the next three to five years, to preserve reliable access to bone probes and provide service levels to their customers, suppliers would need to implement resilient sourcing strategies; have a minimum of two suppliers; produce regionally; create inventory visibility; and implement supply chain visibility within their operations.

Steady growth is expected for the bone probe market due to expected increases in orthopedic surgeries, an aging population, and the demand for minimally invasive procedures and digital surgery. Advancements in technology and product innovations would create new opportunities for smart, ergonomic, sterile, and procedure-specific probes. Affordable and available bone probes would likely have a positive impact on the manufacturing improvements. Restricting the adoption of bone probes would be high costs, complex regulations, and supply chain unpredictability. Competitive edge in this market would be the ability to combine an innovative product offering with reliable and efficient manufacturing and distribution capability. Suppliers that focus on these strategies are expected to sustain growth in the market over the next three to five years.

List of Bone Probe Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies bone probe market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bone probe market companies profiled in this report include-

• LDR Medical
• MicroPort Orthopedics
• Rebstock Instruments GmbH
• Stryker
• Medtronic
• Stille AB
• Alphatec Spine Inc.
• Synthes GmbH
• DePuy Synthes
• gSource

Bone Probe Market by Segment

The study includes a forecast for the global bone probe market by type, application, and region.

Bone Probe Market by Type [Value ($M) from 2019 to 2035]:

• Straight
• Curved
• Angled Curved

Bone Probe Market by Application [Value ($M) from 2019 to 2035]:

• Hospital
• Ambulatory Surgery Center

Bone Probe Market by Region [Value ($M) from 2019 to 2035]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Bone Probe Market

Bone probe market activity is impacted by hospital capital spending, orthopedic device localization, and increasing regulatory constraints. In the next 3 to 5 years, manufacturers focus on navigational, robotic, and reusable instrument systems. In a recent market study by Lucintel, these developments correspond to the demand for specialized probing instruments.

• United States: Stryker reported $3.1 billion in expected research and development spending in 2025 for their Mako, spine and orthopedic systems. This relevant spending supports anticipated purchase of probes and modular instruments with navigation systems in the next 3 to 5 years.
• China: In 2025, China further developed its volume-based procurement system while domestic companies increased their production of orthopedic surgery instruments. This pertains to localized sourcing and centralized purchasing of competitively priced bone probes that meet the requirements of the NMPA.
• Germany: The Medical Device Regulation (MDR) continued to apply throughout the EU and German companies invested in surgical instruments traceability and quality systems. This remains relevant for the performance of procedures and documented reprocessing of instrument systems.
• India: India continued its policy of promoting domestic production of medical devices, while the 2025-26 Union Budget allocated 4,000 crore to healthcare research. This will be important for procurement of locally produced probes and instruments as local manufacturing of orthopedic devices and hospital modernization are expected to increase.
• Japan: Japanese hospitals started adding more robotic and image-guided orthopedic devices. This is important due to the growing need for advanced and precise devices and instruments for minimally invasive procedures along care pathways of an aging population as the revised 2025 reimbursement policies continue to support advanced surgical treatments.

Features of the Global Bone Probe Market

• Market Size Estimates: bone probe market size estimation in terms of value ($M).
• Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
• Segmentation Analysis: bone probe market size by type, application, and region in terms of value ($M).
• Regional Analysis: bone probe market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the bone probe market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bone probe market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the bone probe market by type (straight, curved, and angled curved), application (hospital and ambulatory surgery center), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 7 years and what has its impact been on the industry?